Terms and Conditions for Morivantexa Services
Please review these terms before using Morivantexa. They set expectations for use, safeguarding your rights and outlining our responsibility under Canadian law.
January 17, 2026
Acceptance of Terms
By accessing or using Morivantexa, you accept these terms as legally binding. Continued use indicates agreement, so please discontinue if you disagree.
Definitions
These terms refer to key definitions about platform, service, and user.
- "Platform" means any digital platform operated by Morivantexa for providing automated trade recommendations.
- "User" or "You" refers to individuals accessing, browsing, or using Morivantexa's services.
- "Service" refers to AI-based automated recommendation delivery available through morivantexa.com.
- “Content” covers information, data, trade signals, or materials displayed or transmitted through Morivantexa.
Acceptable Use of Service
Use services solely for your own informational purposes in compliance with Canadian law. Unauthorized commercial use is strictly prohibited.
Eligibility
To use Morivantexa, you must be at least 18 years old and have authority to agree to these terms, abiding by applicable law.
Service is not intended for minors under 18.
User Responsibilities
You agree to provide accurate information and respect platform security requirements at all times.
- Maintain confidentiality of your account credentials.
- Promptly notify us of suspected unauthorized access or misuse.
- Follow applicable Canadian regulations regarding use of automated trade data.
- Use service in a manner consistent with fair practice and these terms.
Prohibited Uses
The following uses are strictly not allowed.
- Attempting to reverse engineer or disrupt security of the platform.
- Transmitting any malicious code or engaging in fraudulent activity.
- Sharing proprietary trade recommendations with unauthorized parties.
- Using the service for unlawful or deceptive purposes.
- Impersonating others or submitting misleading information.
Intellectual Property Notice
All contents, logos, methodologies, and recommendations available on Morivantexa are original works and property of the platform. Users receive a limited, non-transferable right of use.
User-Submitted Content
You may submit questions or feedback, provided these do not infringe any rights or applicable laws.
User Content Rights:
By submitting content, you grant Morivantexa a license to use, display, and process your feedback as needed to improve the service.
Your Privacy Rights and Policy
Your personal information is processed according to our Privacy Policy. We are committed to transparency, compliance, and safeguarding your privacy. Read Privacy Policy
Service Disclaimer and Limitations
All recommendations are informational and not financial instruction.
Essential Warnings:
Recommendations do not guarantee results; decisions rest with users. Past performance does not guarantee future results.
Limitation of Liability Statement
Morivantexa is not liable for indirect, consequential, or special damages. Users are responsible for evaluating all signals and outcomes.
Indemnification
You agree to indemnify Morivantexa against liability from your breaches of these terms or misuse of the platform.
Dispute Resolution Process
We aim to address disputes amicably; unresolved disputes are subject to procedures below.
Arbitration
Disputes will be settled by arbitration under applicable Canadian rules. Arbitration shall occur in the province Morivantexa operates.
Users consent to arbitration as sole remedy for unresolved disputes.
Online Dispute Resolution Information
Alternate pathways for dispute resolution may be available for platform users as applicable under Canadian law.
Read Full Disclaimer: Read Full Disclaimer
Applicable Law and Jurisdiction
This agreement is governed by the laws of Canada and the specific province of Morivantexa’s operations.
Termination
We reserve the right to terminate or suspend access for violations; users may stop using the platform at any time.
Modifications
These terms may be updated as required by legal, process, or policy changes. Continued use means acceptance of new terms.
Severability
If any provision is found invalid, other terms remain effective and enforceable.
Entire Agreement Understanding
These terms constitute the full agreement between Morivantexa and its users, overriding all prior communications.
Contact for Terms Questions
For questions regarding these Terms, reach out to us below.
Email Address: content@morivantexa.com
Phone Number: +1 (392) 214-9215
Mailing Address: 68 Water Street, Suite 401, Vancouver, BC V6B 1A4 Canada
Effective Date: January 17, 2026
Version: 1.2